Intimacy of Women With Cystic Fibrosis — IFAM  

Mucoviscidosis Clinical Trial

Official title: Intimacy of Women With Cystic Fibrosis

Status Completed

Clinical Trial Summary

The intimate life of patients with cystic fibrosis has not been the subject of specific research, it is even left behind in favor of respiratory, digestive or endocrinological dysfunctions endangering these patients. After 16 years of practice, it is significant that this subject is problematic, painful but difficult to tackle; No doubt just as much on the side of caregivers: this question has never found its way into team exchanges, it seems to be evaded doubtless difficult or too intimate to welcome. These disorders arise from the effects of the disease on the health of the mucous epithelial tissues also located in the genital area. These difficulties are more closely approached by the difficulties of procreation; PMA allows them to get around them, nevertheless making it possible to be a parent, with the residual frustration of a satisfactory sex life: a deaf "addition", adding to many care constraints.

It is therefore in terms of sexual health and quality of sexual life that it is desirable to shed light on this aspect of cystic fibrosis in women.

Bibliographic research confirms this approach: this subject is not explored, the rare publications concern the vulnerability of the cervix or the difficulty on both sides of tackling this subject.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Cystic Fibrosis
• Fibrosis
• Mucoviscidosis

• NCT number: NCT04225962
• Study type: Observational
• Source: Hospices Civils de Lyon
• Status: Completed
• Start date: November 19, 2019
• Completion date: May 18, 2021